CCR4 and familial pancreatic carcinoma: In this study, the cytokine‒cytokine receptor interaction pathway was the most enriched pathway between pancreatic cancer cells treated with and without glutamine, includingCCL5,CCR4,LTA,CXCR4,IL-6R, andIL-7R (Figure 8C).